Amalgamated Bank Pacira Bio Sciences, Inc. Transaction History

Amalgamated Bank

$12.1 Billion
Q3 2024

A detailed history of Amalgamated Bank transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Amalgamated Bank holds 13,682 shares of PCRX stock, worth $266,388. This represents 0.0% of its overall portfolio holdings.

Number of Shares

13,682

Previous 14,201 3.65%

Holding current value

$266,388

Previous $406,000 49.26%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 30, 2024	SELL	$11.7 - $28.46 $6,072 - $14,770	-519 Reduced 3.65%	13,682 $206,000
Q2 2024 Aug 12, 2024	SELL	$25.5 - $31.51 $1,326 - $1,638	-52 Reduced 0.36%	14,201 $406,000
Q1 2024 Apr 23, 2024	SELL	$27.7 - $35.48 $157,779 - $202,094	-5,696 Reduced 28.55%	14,253 $416,000
Q4 2023 Feb 06, 2024	SELL	$26.32 - $34.31 $12,054 - $15,713	-458 Reduced 2.24%	19,949 $673,000
Q3 2023 Nov 08, 2023	SELL	$30.68 - $40.09 $14,480 - $18,922	-472 Reduced 2.26%	20,407 $626,000
Q2 2023 Aug 11, 2023	BUY	$36.12 - $47.5 $2,600 - $3,420	72 Added 0.35%	20,879 $836,000
Q1 2023 May 02, 2023	SELL	$35.53 - $43.38 $53,543 - $65,373	-1,507 Reduced 6.75%	20,807 $849,000
Q4 2022 Feb 10, 2023	SELL	$38.19 - $57.45 $2,024 - $3,044	-53 Reduced 0.24%	22,314 $862,000
Q3 2022 Nov 09, 2022	BUY	$51.24 - $58.89 $29,821 - $34,273	582 Added 2.67%	22,367 $1.19 Million
Q2 2022 Aug 15, 2022	SELL	$51.49 - $81.64 $5,406 - $8,572	-105 Reduced 0.48%	21,785 $1.27 Million
Q1 2022 Jun 30, 2022	SELL	$60.03 - $76.49 $64,532 - $82,226	-1,075 Reduced 4.68%	21,890 $1.67 Million
Q4 2021 Feb 15, 2022	SELL	$47.97 - $62.21 $13,767 - $17,854	-287 Reduced 1.23%	22,965 $1.38 Million
Q3 2021 Oct 29, 2021	SELL	$54.64 - $61.3 $13,441 - $15,079	-246 Reduced 1.05%	23,252 $1.3 Million
Q2 2021 Aug 16, 2021	BUY	$59.18 - $69.99 $1.01 Million - $1.19 Million	17,050 Added 264.42%	23,498 $1.43 Million
Q1 2021 May 13, 2021	SELL	$59.31 - $78.82 $34,933 - $46,424	-589 Reduced 8.37%	6,448 $452,000
Q4 2020 Feb 12, 2021	BUY	$50.47 - $66.26 $8,882 - $11,661	176 Added 2.57%	7,037 $421,000
Q3 2020 Oct 30, 2020	SELL	$51.97 - $63.0 $6,392 - $7,749	-123 Reduced 1.76%	6,861 $412,000
Q2 2020 Aug 10, 2020	SELL	$30.8 - $52.47 $21,159 - $36,046	-687 Reduced 8.96%	6,984 $366,000
Q1 2020 May 13, 2020	SELL	$28.4 - $50.7 $7,043 - $12,573	-248 Reduced 3.13%	7,671 $257,000
Q4 2019 Feb 13, 2020	BUY	$36.31 - $46.83 $26,179 - $33,764	721 Added 10.02%	7,919 $359,000
Q3 2019 Nov 13, 2019	SELL	$35.66 - $44.99 $3,601 - $4,543	-101 Reduced 1.38%	7,198 $274,000
Q2 2019 Aug 14, 2019	BUY	$36.57 - $47.97 $44,615 - $58,523	1,220 Added 20.07%	7,299 $317,000
Q1 2019 May 15, 2019	BUY	$36.47 - $42.17 $8,825 - $10,205	242 Added 4.15%	6,079 $231,000
Q4 2018 Feb 15, 2019	BUY	$41.31 - $52.16 $241,126 - $304,457	5,837 New	5,837 $251,000
Q1 2018 May 22, 2018	SELL	$29.98 - $46.35 $160,093 - $247,509	-5,340 Closed	0 $0
Q4 2017 Feb 13, 2018	BUY	$31.85 - $46.95 $170,079 - $250,713	5,340	5,340 $244,000

Others Institutions Holding PCRX

# of Institutions

263

Shares Held

50.4M

Call Options Held

429K

Put Options Held

391K

View Full List

About Pacira BioSciences, Inc.

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $892M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

More about PCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.

Account

Amalgamated Bank Pacira Bio Sciences, Inc. Transaction History